Anishiya Abrol > Hogan Lovells US LLP > Washington DC, United States > Lawyer Profile

Hogan Lovells US LLP
United States

Work Department

Intellectual Property




Anishiya Abrol supports companies in their development and commercialization of cutting-edge medical therapies and tools. She advises on and negotiates a variety of strategic transactions from collaborations to in-licensing and out-licensing to maximize intellectual property assets, and then assists the company in implementing and integrating the new assets.

Anishiya has been seconded to multiple life sciences companies. She knows the issues facing in-house counsel and works closely with members of the firm’s Regulatory and Privacy Practice groups to provide integrated and practical advice.

Anishiya’s practice encompasses the full life sciences life cycle, from the discovery in the lab to dispensing to a patient. She has an undergraduate science degree, and her curious nature draws her towards early stage research and development transactions and activities, including clinical trial agreements, material transfer agreements, contract research organization (CRO) agreements, core lab agreements, sponsored research, grants, and technology transfers, both domestically and internationally. Recognizing though that a therapy’s primary value lies in the hands of patients, she assists commercialization efforts with support on distribution agreements, specialty pharmacy agreements, co-promotion agreements, authorized generic agreements, out-licensing arrangements, and other similar commercial activities.




Chair, Wills for Heroes Program, Virginia Bar Association (2008-2013)
Member, American Health Law Association
Member, Virginia Bar Association


J.D., George Mason University School of Law, magna cum laude, 2004
B.A. Biology, University of Virginia, 1997
B.A. History, University of Virginia, 1997

Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

(Next Generation Partners)

Anishiya AbrolHogan Lovells US LLP

In addition to ‘outstanding expertise with small to mid-sized public biotech and pharma companies’ Hogan Lovells US LLP is also able to act for international pharmaceuticals companies. The team’s regulatory capacity is a key factor in this, advising on FDA clearances and post-approval compliance. IP is another area of expertise, primarily in transactions where the team provides diligence support in major capital markets and M&A matters and acts on IP litigation. It also has a strong product liability offering led by Baltimore-based Lauren Colton, which advises on medical devices and pharmaceuticals. The Washington DC office is led by biologics risk evaluation expert Lynn Mehler, experienced biopharmaceutical startup advisor Philip Katz and Randy Prebula, who gives regulatory advice to medical device and technology companies. Also DC-based is David Fox, who is known for his Hatch Waxman compliance expertise. Philadelphia-based team leader Steve Abrams is known for transactional work. Also recommended are DC-based Anishiya Abrol and Philadephia-based Blake Wilson.